Loading company…
Riskpilot
← Back to search
Sign in
Get full access
GRAVDAL FOTTERAPI AS
AS
Active
Org 932161397
C/O Microklinikken Lierbakkene 53, 3425 Reistad
Other human health activities n.e.c. · NACE 8699
Est. 2023
1 employees
www.microklinikken.no
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 806K
+52% vs 2024
EBITDA margin
1.2%
+134% vs 2024
Equity ratio
-24.8%
Financial strength
Net profit 2025
NOK 9K
+128% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 806K
+52%
EBITDA
NOK 9K
+134%
Net profit
NOK 9K
+128%
Total assets
NOK 66K
+72%
Equity
NOK -16K
+37%
Employees
1
—
Company information
Legal name
GRAVDAL FOTTERAPI AS
Org number
932161397
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
2. oktober 2023
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Fotterapi og andre helsetjenester.
Contact
Address
C/O Microklinikken Lierbakkene 53, 3425 Reistad
Website
www.microklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities n.e.c.
Companies in Lier
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
16
530
806
Staff expenses
−0
−277
−500
EBITDA
−22
−28
9
Depreciation & amort.
−0
−0
−0
EBIT
−22
−28
9
Net financials
0
0
0
Profit before tax
−22
−28
9
Tax
−6
6
−0
Net profit
−16
−34
9
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
20
39
66
Equity
8
−26
−16
Long-term debt
0
0
0
Short-term debt
11
64
83
Total debt
11
64
83
Financial ratios
5-year trend
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
2023
2025
Equity ratio
-24.8%
This company
38.2%
Market median
-165% vs market
2023
2025
Return on equity
949600.0%
This company
18.4%
Market median
+5160770% vs market
2023
2025
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
2023
2025
Asset turnover
12.16×
This company
1.12×
Market median
+986% vs market
2023
2025
Debt / equity
5.04×
This company
0.62×
Market median
-713% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MG
Maren Gravdal Nguyen
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KT
Kim Tony Gravdal Nguyen
Board of Directors
2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of GRAVDAL FOTTERAPI AS also hold positions in
0
other companies.
Person
Role here
Other companies
Maren Gravdal Nguyen
Chief Executive Officer
0 companies
Kim Tony Gravdal Nguyen
Board of Directors
0 companies